The tenofovir alafenamide fumarate market has been growing steadily, driven by increasing prevalence of HIV and hepatitis B, as well as advancements in antiretroviral therapy. Tenofovir alafenamide fumarate (TAF) is an antiretroviral medication used in the treatment of HIV-1 and chronic hepatitis B. It is a prodrug of tenofovir, which is a nucleotide reverse transcriptase inhibitor...